http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090090747-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4760eef93105d1e7188db2d0b1fa4ff5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
filingDate 2008-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58842d10d87cb32b0c7b142aee8bd35c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3a86d62e863d1dcddd72493307b3c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e65d5d39b761a537dd1d61f65f5829c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28cd71b4ec1bccae06540f6150aef28
publicationDate 2009-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090090747-A
titleOfInvention Anti-vascular disease treatment containing combination ingredients
abstract The present invention provides a vascular disease prophylactic agent comprising a calcium channel blocker and an antiplatelet agent. The anti-vascular disease treatment agent according to the present invention has a significant decrease in blood pressure characteristics, effects, and duration of action compared to the administration of a single substance when administered to the body, and is further enhanced to significantly reduce the dosage of individual active ingredients.
priorityDate 2008-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415841566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425535208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448700180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883467

Total number of triples: 49.